References
- Ardizzone S, Bianchi Porro G. A practical guide to the management of distal ulcerative colitis. Drugs 1998;55:519–42.
- Odze R, Antonioli D, Peppercorn M, Goldman H. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol 1993;17:869–75.
- Biddle WL, Greenberger NJ, Swan JT, McPhee MS, Miner PB Jr. 5-aminosalicylic enemas: effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 1988; 94: 1075–9.
- D’Albasio G, Trallori G, Ghetti A, Milla M, Nucci A, Pacini F, Morettini A. Intermittent therapy with high-dose 5-aminosa- licylic acid enemas for maintaining remission in ulcerative proctosigmoiditis. Dis Colon Rectum 1990;33: 394–7.
- Andreoli A, Spinella S, Levenstein S, Prantera C. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Ital J Gastroenterol 1994;26:121–5.
- D’Albasio G, Pacini F, Camarri E, Messori A, Trallori G, Bonanomi AG, et al. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. Am J Gastroenterol 1997;92: 1143–7.
- Marteau P, Crand J, Foucault M, Rambaud J-C. Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomized double-blind placebo controlled multicentre study. Gut 1998;42: 195–9.
- Kaplan EL, Meier P. Nonparametric evaluation from incomplete observations. J Am Stat Assoc 1958;53:457–81.
- Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163–70.
- Hanauer S. Drug therapy: inflammatory bowel disease. N Engl J Med 1996;334:841–7.
- Cohen RD, Woseth DM, Thisted RA, Hanauer SB. A metaanalysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000;95:1263–76.
- Mantzaris GJ, Hatzis A, Petraki K, Spiliadi C, Triantaphyllou G. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis. Dis Colon Rectum 1994;37: 58–62.
- Sutherland LR, Martin F. 5-aminosalicylic acid enemas in the maintenance ofremission in distal ulcerative colitis and proctitis. Can J Gastroenterology 1987;1:3–5.
- Hanauer SB, Schultz PA. Relapse rate after successful treatment of refractory colitis with 5-ASA enemas. Gastroenterology 1987; 92:1424.
- Riley SA. What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis? Gut 1998;42:761–3.
- Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol 1992;14:309–17.
- Hay AR, Hay JW. Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol 1992;14:318–27.